• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

'12 NHS Claiming MUS are medically explained & this is a 'more empowering, recovery-focused approach

Esther12

Senior Member
Messages
13,774
I saw ME Agenda linking to this and thought that it could be of interest to some here.

edit: Realised that this title could make this seem more important that it is, it's an NHS document, but just one of many. The forum's software limited the length of my title, so I had to cut bits out.


It's not really important though, and feel like I keep linking to frustrating things at the moment - sorry! Probably best to ignore, but I thought I'd store it here in case it's ever wanted as a historical document!

Best bit imo:

Medically Unexplained or Physiologically Explainable Symptoms?
Physical symptoms which are not caused by physical disease or injury are very common, and can become very distressing and disabling. They can be caused by over-use (e.g. ‘cramp’ or tiredness) or over-breathing (e.g. ‘pins and needles’ or giddiness) but are usually explained by natural physiological processes.1 They are often explainable by reference to very well established physiological explanations of stress on the body, e.g. lactate build-up in muscles with over-use or acid-base imbalances from hyperventilation causing giddiness or tingling. They can be a result of an interaction between the physical trigger for the symptoms (e.g. a virus or an acute injury) and an individual's cognitive, behavioural and emotional responses which may perpetuate these symptoms. Many patients with these symptoms meet criteria for a recognised syndrome such as chronic fatigue syndrome, irritable bowel syndrome, non-cardiac chest pain and fibromyalgia. They can also be a result of anxiety or depression which needs treatment in its own right.


Describing these symptoms as medically unexplained is incorrect, confusing and even frightening to those experiencing and not understanding them – more empowering, recovery-focused approaches are evidence-based.


Why specific symptoms occur may be explained by the context and prior experience of the person concerned - so may have psychological significance e.g. the interpretation of chest pain as due to a heart attack when a close relative has recently died of this. Persistent and more severe symptoms – often referred to as somatoform disorders - can benefit from intervention, e.g. cognitive behaviour therapy or graded exercise therapy, and even more complex ones from liaison services.


http://www.emotionalwellbeing.south...cle/368-case-for-change-physical-health-final

Emotional Wellbeing & Physical Health Care
Case for Change

1. Reduce Waste In General Hospitals By Acute Care Commissioning Of Psychiatric Liaison Services To Emergency Departments And Wards

2. Change Understanding And Practice In Primary, Community And Secondary Care Towards ‘Physiologically Explainable’ Symptoms And The Interaction Of Emotional Wellbeing With Long-term Conditions

3. Maximise Physical Health Gain In People With Severe Mental Illness Through Collaboration Between Primary, Secondary And Mental Health Services


Acute care commissioning of liaison services can reduce distress and disability whilst cutting bed usage, unnecessary investigations and hospital visits.

People with severe mental illness die early and avoidably: collaboration between primary care and mental health services to ensure regular health checks and then responsiveness when they do attend, could change this - especially with those most difficult to reach.



Medically Unexplained or Physiologically Explainable Symptoms?
Physical symptoms which are not caused by physical disease or injury are very common, and can become very distressing and disabling. They can be caused by over-use (e.g. ‘cramp’ or tiredness) or over-breathing (e.g. ‘pins and needles’ or giddiness) but are usually explained by natural physiological processes.1 They are often explainable by reference to very well established physiological explanations of stress on the body, e.g. lactate build-up in muscles with over-use or acid-base imbalances from hyperventilation causing giddiness or tingling. They can be a result of an interaction between the physical trigger for the symptoms (e.g. a virus or an acute injury) and an individual's cognitive, behavioural and emotional responses which may perpetuate these symptoms. Many patients with these symptoms meet criteria for a recognised syndrome such as chronic fatigue syndrome, irritable bowel syndrome, non-cardiac chest pain and fibromyalgia. They can also be a result of anxiety or depression which needs treatment in its own right.


Describing these symptoms as medically unexplained is incorrect, confusing and even frightening to those experiencing and not understanding them – more empowering, recovery-focused approaches are evidence-based.


Why specific symptoms occur may be explained by the context and prior experience of the person concerned - so may have psychological significance e.g. the interpretation of chest pain as due to a heart attack when a close relative has recently died of this. Persistent and more severe symptoms – often referred to as somatoform disorders - can benefit from intervention, e.g. cognitive behaviour therapy or graded exercise therapy, and even more complex ones from liaison services.

How much of a problem are physiologically explainable symptoms?
    • Physical symptoms which are not caused by physical disease or injury are extremely common with many people experiencing them most days (e.g. headache, cramp, tiredness) but not normally requiring medical intervention. However quite commonly, people present and re-present to primary care or emergency departments because of concern that these physical symptoms may be caused by a physical disease.
    • 19 per cent of new primary care GP appointments, especially frequent attenders, were found to be for people whose symptoms were previously described as ‘medically unexplained’ (PES (‘MUS’)) but may be better described as physiologically explainable2-3.
    • In secondary care (physical health trusts/services), a number of studies in both the UK and the United States have shown that up to 50 per cent of sequential new attenders at outpatient services have PES (‘MUS’). For example, percentage with PES (‘MUS’) in new attenders at the outpatient department, King’s College Hospital, London4 by specialty were found to be:
      • Chest (59%)
      • Cardiology (56%)
      • Gastroenterology (60%)
      • Rheumatology (58%)
      • Neurology (55%)
      • Gynaecology (57%)
      • Dental (49%)
    • Analysis of 2008/2009 NHS figures shows that people with these problems account for as many as:
      • one in five new consultations in primary care,
      • 7 per cent of all prescriptions,
      • 25 per cent of outpatient care,
      • 8 per cent of inpatient bed days, often repeat admissions, and
      • 5 per cent of A&E attendances,
    • Women are three to four times more likely to experience PES (‘MUS’) than men.5
What works?
    • Primary care interventions focus on the consultation style adopted by professionals rather than defined psychological interventions (summarised in Improving Access to Psychological Therapies (IAPT) guidance7 and the recent Forum for Mental Health in Primary Care guidelines8.
    • ‘Symptom reattribution’ has been found to be a successful form of intervention for people with PES (‘MUS’): this is a structured consultation delivered by GPs which provides a psychological explanation to patients with somatised disorder9. However, while it does improve doctor-patient communication, it may not improve patient outcomes10.
    • Identification and management of symptoms and treatment of any associated symptoms of depressionor anxiety in accordance with the relevant National Institute for Health and Clinical Excellence (NICE) guidelines can be beneficial to those disorders. However, successful psychological treatment is usually dependent on treatment models specific to the PES (‘MUS’) delivered by therapists with training in this area.
    • Specialist services where persistent symptoms present are more successful where they focus on specific syndromes, e.g. chronic fatigue syndrome or irritable bowel syndrome.
    • Liaison teams provide multidisciplinary care for patients presenting with more complex PES (‘MUS’) including associated high levels of disability and high levels of distress11.
    • Pain, fatigue or more generic clinics, e.g. rheumatology or G-I, may have psychological intervention integrated within them; this collaborative model may be more acceptable to patients presenting and improve identification and management
    • A meta-analysis of treatment for chronic fatigue syndrome suggests that both CBT and graded exercise therapy are promising treatments, with CBT possibly the more effective treatment in patients who have co-morbid anxiety and depressive symptoms12.
    • Psychological treatments are effective for irritable bowel syndrome (including CBT and psychotherapy, either alone or in conjunction with antidepressant medications)13, fibromyalgia,14 and multisomatoform disorder (brief psychodynamic psychotherapy)15.
  • Positive outcomes depend on:
    • Provision of empowering ‘normalising’ physiological explanations of symptoms in primary, community and secondary care16.
    • Where symptoms persist, offering prompt intervention using ‘low intensity’ or ‘high intensity’ psychological interventions based on a clear biopsychosocial understanding and formulation of these conditions
    • Availability of specialist services (e.g. fatigue or pain services) or psychiatric liaison teams for further care especially where physical illness complicates, restoration of function has not occurred or where substantial acute service resources being used.
What is actually available?
    • Primary care can be very effective in managing physiological explainable symptoms but unfortunately this remains very variable. Improvements in this area could be highly cost-effective17.
    • Persistent symptoms can respond to NICE-approved psychological treatments available through IAPT; extension of these services will have ‘knock-on’ effects through primary, community and secondary care.
    • More complex cases are treated in specialist services where these exist. However liaison psychiatry and linked psychology service availability is uneven.
What information is there on cost?
    • Estimated cost to the NHS associated with PES (‘MUS’) of £3.1 billion17. However, about half the cost (£1.2 billion) was spent on the inpatient care of less than 10 per cent of people with PES (‘MUS’) – a relatively small number of people receive very expensive and inappropriate care.
    • While the economic case for CBT is most compelling if resources are targeted at those with full somatoform disorders, the case for also tackling sub-threshold conditions is strong. All models are likely to be cost saving in the long-term.
    • Cost models rely on evidence of effectiveness from studies in the United States, which may not be easily generalizable to an English context. However, sensitivity and threshold analyses indicate that, even assuming very limited improvements in health outcomes, investing in actions to tackle somatoform disorders remains cost-effective from a societal perspective under most scenarios.
    • Pathways can be developed for 'functional/MUS/physiological explainable symptoms’ with evidence for cost savings being greatest at the severe end using collaborative care.
    • More information is required on the relative effectiveness of e-learning compared to face-to-face learning as a way of raising GP awareness, because costs are substantially lower.
Impact of Emotional Wellbeing on Physical Conditions
How common a problem is this?

    • One in four of GP’s patients will need treatment for mental health problems at any time18.
    • At least 25 per cent of patients with a physical illness admitted to hospital also have a diagnosable mental health condition;
    • A further 41 per cent have sub-clinical symptoms of anxiety or depression, with rates rising to 60 per cent for the over-60s.19 Dementia is also a very important issue (see Dementia Commissioning Pack)20
    • Patients with a physical illness are three to four times more likely to develop a mental illness than the rest of the population;
A recent study of frequent attenders at emergency departments in Cambridge identified at least three subgroups with mental health-related presentations:

    • Moderate frequent attenders (defined as six–20 presentations per year) with unattributed PES ('MUS' presenting with abdominal complaints in particular),
    • Moderate frequent attenders with undiagnosed mental health and long-term physical health co-morbidities, and
    • Extreme frequent attenders (more than 20 presentations per year) with repeated self harm and substance misuse problems.21
The common problems acute liaison services address are:18 19

    • Mental disorder accounts for around five per cent of A&E attendances, 25% of primary care attendances, 30% of acute inpatient bed occupancy and 30% of acute readmissions
    • Self-harm accounts for between 150,000 and 170,000 A&E attendances per year in England
    • MUS may account for up to 50% of acute hospital outpatient activity
    • 13–20% of all hospital admissions and up to 30% of hospital admissions via A&E at weekends are related to alcohol
    • In England, alcohol-related hospital admissions doubled in the 11 years up to 2007, and alcohol-related deaths also doubled in the 15 years to 2006
    • One-quarter of all patients admitted to hospital with a physical illness also have a mental health condition that, in most cases, is not treated while the patient is in hospital
    • Most patients who frequently re-attend A&E departments do so because of an untreated mental health problem
    • Self-harm is the third most common reason for unscheduled medical admission
    • Two-thirds of NHS beds are occupied by older people, up to 60% of whom have or will develop a mental disorder during their admission
Long-term conditions
    • Over 30 per cent of all people say that they suffer from a long-term condition.18
      • This group account for 52 per cent of all GP appointments, 65 per cent of all outpatient appointments and 72 per cent of all inpatient bed days.23
      • 70% of NHS spending goes on the treatment of LTCs, a great deal of which currently involves treatment in acute hospitals.23
    • People with one long-term condition are two to three times more likely to develop depression than the rest of the population. People with three or more conditions are seven times more likely to have depression
    • Mental health problems such as depression are much more common in people with physical illness. Having co-morbid physical and mental health problems delays recovery from both
    • Adults with both physical and mental health problems are much less likely to be in employment
    • Depression in people with coronary heart disease (CHD) predicts further coronary events and greater impairment in health-related quality of life. Depressed individuals with CHD are more than twice as likely to die as those with CHD alone.24-25
    • Patients with chronic obstructive pulmonary disease (COPD) have a higher prevalence of anxiety and depression than the general population26-27; it is estimated that up to 40% of COPD patients have symptoms of depression and 34% anxiety.28 Psychological distress (such as anxiety and depression) can have an impact on symptoms and on how people manage their condition.29
Coronary heart disease
    • European guidelines on cardiovascular disease prevention41describe that
      • Depression predicts cardiovascular events and worsens prognosis;
      • Depression at least doubles the risk of a major cardiac event;
      • In patients with CHD, depression has effects on cardiac symptoms, overall quality of life and illness behaviour including increased healthcare utilisation, low adherence to treatment and lowered rates of return to work.
    • People who have suffered a heart attack, unsurprisingly, have a 30 per cent chance of developing depression – which can be helped in its own right.30
    • Those with cardiac problems are approximately three times more likely to die of these causes if they also suffer from depression than if they do not.31
    • Depression in people with CHD predicts further coronary events (odds ratio = 2.0) and greater impairment in health-related quality of life.24-25
    • People who develop depression following acute coronary syndrome, as opposed to those with depression that pre-dates the acute coronary syndrome, may be at particularly high risk of worse cardiac outcomes.31
    • Depressed individuals with CHD are more than twice as likely to die as those with CHD alone.24 25 The mechanisms behind the association between depression and either mortality or morbidity in physical illness are not fully understood.33 Either diminished healthcare behaviour or physiological impairment, or a combination of the two, may be important.
What do service users and carers want?
Service users and carers consistently say that they want:

    • Good services provided in a holistic way for their emotional and physical wellbeing,
    • To be listened to and treated with respect
    • Effective treatments
    • To be provided with information about their conditions.
What works?
In primary care, collaborative care described in the NICE guideline35 has been successful in the United States.36 It involves37:

    • Multi-professional approach to patient care provided by a case manager working with the family doctor under weekly supervision from specialist mental health medical and psychological therapies clinicians
    • A structured management plan of medication support and brief psychological therapy
    • Scheduled patient follow-ups
    • Enhanced inter-professional communication patient-specific written feedback to family doctors via electronic records and personal contact.
In diabetes:

    • Collaborative care reduces glycosylated haemoglobin as well as co-morbid depressed mood and systolic blood pressure38, and a recent meta-analysis has confirmed the positive effect on diabetes outcomes.38
    • Addressing psychological needs has been shown to improve glycosylated haemoglobin (HbA1c) by 0.5 to 1 per cent in adults with Type 2 diabetes.38-39
    • Improvements with psychological intervention include reduced psychological distress and anxiety; improved mood and quality of life; improved relationships with health professionals and significant others; and improved eating-related behaviours such as binge eating, purging and body image symptoms.40
With coronary heart disease:

    • Psycho educational interventions significantly reduce angina frequency and medication use and psychological wellbeing in patients with stable angina.41
    • NICE-approved psychological therapies have been shown to:
      • Improve the psychological, symptomatic and functional status of patients newly diagnosed with angina.42
      • Reduce hospital admissions in refractory angina patients.44
    • A very recent review44 found 16 trials of psychological and pharmacological interventions for depression co-morbid with CHD. There was a small but clinically meaningful effect of psychological interventions and SSRI antidepressants on depression outcomes in CHD patients but there were no effects on mortality rates or cardiac events.
    • In the year following the brief cognitive behavioural intervention for patients with chronic refractory angina43, patients exhibited 5-10 fewer inpatient bed days associated with cardiac admissions on average, and 0.75 fewer inpatient bed days associated with myocardial infarction.
Psychological needs of patients and carers exist with other long-term conditions including, for example:

    • Post-stroke, neurodegeneration, epilepsy, sickle cell disease, cancer, renal disorders HIV/AIDS, gastro-intestinal conditions
    • Evaluation of the promising efficacy of psychological therapies and economic arguments of actual or potential savings associated with provision of psychological care in these areas is being developed.47
In secondary care, liaison services have been shown to bring the following benefits48:

    • Improved patient self-management of their care
    • Assessment, engagement, formulation and treatment with reduced healthcare costs, of patients who may be reluctant to attend other mental health services and including those with physiologically explainable symptoms PES (‘MUS’)
    • Improved physical and mental health outcomes, e.g. improvement of clinical outcomes of depression49-50 which is an independent predictor of readmission at six months in the elderly51
    • Support with patients admitted to medical wards with severe anorexia nervosa who are at high risk from combined physical, psychological and behavioural problems
    • Improved return to independent living for the elderly52
    • Reduced stigma associated with mental health care
    • Advocacy directly for the physical care of those with mental health problems in acute services
    • Reduction in readmissions and length of stay53
    • Advice on, and where appropriate, management of complex issues to do with the Mental Health Act and Mental Capacity Act
    • Reduction in subsequent healthcare utilisation, including emergency care and clinic visits51
    • Improved mental health skills and wellbeing of staff in acute hospital settings
    • Assistance in relieving the stress that staff often feel when dealing with patients with complex needs and this reducing levels of sickness absence
Liaison services aim to increase the detection, recognition and early treatment of impaired mental wellbeing and mental disorder to:

    • Reduce excess morbidity and mortality associated with co-morbid mental and physical disorder
    • Reduce excess lengths of stay in acute settings associated with co-morbid mental and physical disorder
    • Reduce risk of harm to the individual and others in the acute hospital by adequate risk assessment and management
    • Reduce overall costs of care by reducing time spent in A&E departments and general hospital beds, and minimising medical investigations and use of medical and surgical outpatient facilities
    • Ensure that care is delivered in the least restrictive and disruptive manner possible.
Priorities for development in all general hospitals are services for:

  • Acute mental health presentations to the Emergency Department including self-harm
  • Acute mental health issues on wards especially delaying discharge (mainly depression but also organic psychosis, personality disorders impacting on treatment, advice on capacity, complex diagnoses, and advice on the use of psychopharmacology)
What is actually available?
In primary care:

  • The impact of the care provided for people with physical conditions, especially long-term, on their emotional and physical wellbeing in hampered by lack of outcome measurement – as is the case in primary and mental health care
  • IAPT services now have a focus on providing care for emotional problems comorbid with long term conditions and pathfinder sites have recently set up for PES (‘MUS’)
In secondary care, liaison teams exist in many University hospitals but are less common in other general hospital settings. Psychologists are part of multidisciplinary teams in some departments. This has tended to happen in a non-systematised way where the value of evidence-based practices is recognised by local clinicians and so may be provided by:

    • Clinical and/or health psychologists embedded in medical teams, such as oncology, diabetes, renal, rheumatology or respiratory teams and providing specialist talking therapies, assessment, consultation, training and research
    • Chronic pain management teams and chronic fatigue teams, operating over a wider area than a single acute hospital
    • Cancer network of psychosocial support professionals, organised to support sophisticated training arrangements for medical and nursing oncology staff (and often including liaison psychiatrists)
    • Cardiac and pulmonary rehabilitation teams
What information is there on cost?
Between £8 billion and £13 billion of NHS spending in England is attributable to the consequences of co-morbid mental health problems among people with long-term conditions57

Wastage includes:

    • Unnecessary investigation;
    • Increased presentations in primary care, emergency departments and outpatient clinics;
    • Increased use of medication;
    • Increased, usually unscheduled, admissions with longer lengths of stay;
    • In older people, increased risk of institutionalisation.
    • For example, co-morbid depression is associated with a 50–75 per cent increase in health spending among diabetes patients54, and yet only half of the cases of depression in diabetes are detected.55
    • At least 28 per cent of patients admitted to hospital with physical illness also have a significant mental health problem, and a further 40 per cent have sub-clinical depression or anxiety.55
    • This rises to at least 60 per cent for people over the age of 60.56
    • Co-morbid mental health problems are a major cost driver in the care of long-term conditions35:
      • Associated with a 45–75 per cent increase in service costs.
      • At least £1 in every £8 spent on long-term conditions is linked to poor mental health and wellbeing, meaning that between £8 billion and £13 billion of NHS spending in England
      • Majority of these costs will be associated with the most complex patients whose long-term conditions are most severe or who have multiple co-morbidities.
    • There is considerable scope for NHS savings and health gains for patients through improving the care pathways and delivering appropriate psychological interventions for patients with diabetes and co-morbid common mental health problems.
    • Collaborative care for patients with Type 2 diabetes and co-morbid depression36:
      • Delivered in a primary care setting to individuals with co morbid diabetes and depression.
      • Estimate that the total cost of six months of collaborative care is £682, compared with £346 for usual care.
      • A two-year evaluation in the United States found that, on average, collaborative care achieved an additional 115 depression-free days per individual; total medical costs were higher in year one, but there were cost savings in year two.36
      • Investing in six months of collaborative care in England for patients with newly diagnosed cases of Type 2 diabetes who screen positive for depression, compared with care as usual. The costs associated with screening are not included in the baseline model. Existing data on the cost effectiveness of CBT were used to estimate the impact on healthcare and productivity losses.
      • Estimated costs and savings for 119,150 new cases of Type 2 diabetes in England in 2009: assumed that 20 per cent of patients under collaborative care would receive CBT, compared with 15 per cent of the usual care group.
      • Assuming 20 per cent screen positive for co-morbid depression, completing and successfully responding to collaborative care leads to an additional 117,850 depression-free days in Year 1 and 111,860 depression-free days in Year 2. Substantial additional net costs in Year 1 due to the costs of the treatment but in Year 2, net savings for the health and social care system due to lower costs in the intervention group, plus further benefits from reduced productivity losses.
      • Using a lower 13 per cent rate of co-morbid diabetes and depression, total net costs in Year 1 would be more than £4.5 million, while net savings in Year 2 would be more than £450,000.
    • In the year following a brief cognitive behavioural intervention for patients with chronic refractory angina43
      • Patients exhibited 5-10 fewer inpatient bed days associated with cardiac admissions on average, and 0.75 fewer inpatient bed days associated with myocardial infarction.
      • On this basis, the study demonstrates reductions in healthcare usage of approximately £2,000 per person in the year after treatment, well in excess of the cost of psychological intervention.
    • Adaptive pacing therapy (APT), cognitive behaviour therapy (CBT), or graded exercise therapy (GET) for patients with chronic fatigue syndrome resulted in improvements in health-related quality of life in comparison with specialist medical care (SMC) which produced little change.
      • At a threshold of £30,000 per QALY, CBT had a 62.7% likelihood of being the most cost-effective option from a healthcare perspective followed by GET at 26.8%;
      • CBT had a 59.5% likelihood of being the most cost-effective option from a societal perspective.
Evaluation of the Rapid Assessment Interface and Discharge (RAID) liaison service in Birmingham demonstrated improvements in health and wellbeing and in cost savings.60-61 An independent economic evaluation was undertaken by the London School of Economics showing:

    • Demonstrated total incremental savings from RAID to be in the order of £3.55 million a year, that is 14,500 bed days saved at £245 per bed day
    • In comparison with the incremental cost of RAID was £0.8 million a year.
    • Benefit: cost ratio is therefore in excess of 4:1, or a saving of £4 for every £1 invested which may well be an underestimate of potential cost savings.
    • Additional benefits may be derived from decreased health resource usage as a result of:
      • Improvements in the health and quality of life of patients,
      • Improvement in the identification of mental health problems,
      • The signposting of patients to more appropriate mental health pathways;
      • Impact on elective admissions (evaluation only considered emergency admissions);
      • Increased discharge of older people to their homes
      • Decreased discharge to residential or nursing homes and hence potential savings in the social care sector.60
Commissioners are required to improve quality while at the same time increasing productivity (QIPP). Liaison services provide an excellent opportunity to do this by:

    • Improving clinical outcomes
    • Reducing admissions to and lengths of stay in acute settings
    • Ensuring patients with co-morbid long term conditions receive better treatment while using fewer health care resources
    • Treating and reducing costs for patients with PES (‘MUS’)
    • Reducing psychological distress following self-harm, and reducing suicide.
Liaison services are usually commissioned by the commissioners of mental health services. However the major benefits in health gain and cost that can accrue from liaison services occur within acute services. There is therefore a case for funding of liaison services to move to become a responsibility of commissioners of acute hospital care to realise these potential cost-benefits.



Physical Care For People With Severe Mental Illness
How much of a problem is it?

    • The life expectancy for a male with psychosis (schizophrenia) is 15–20 years less than average with more than 60 per cent of premature deaths not directly related to suicide.62
    • There are many reasons for this high death rate but failure to prevent, diagnose and treat are included and could be remedied.
    • Fifty per cent of people with mental health problems have a co morbid physical illness.
    • In a study of young people (85 young people aged 16 to 27 years) treated for first episode psychosis, a third had metabolic syndrome or showed metabolic abnormalities.63
    • Smoking is the main cause of preventable death in the general population.
      • People with a mental disorder smoke much more than people without a mental disorder: they consume 42% of all tobacco consumed in England.
      • 59% of people with a first episode of psychosis smoke – a rate 6x higher than non psychotic peers.64
      • Increased smoking is responsible for most of the excess mortality of people with severe mental health problems. 62
    • Obesity is of similar concern:
      • It is likely to be the prime cause of higher rates of type-2 diabetes
      • It is also socially excluding, greatly distresses services users especially in the early phase of rapid weight gain and contributes to treatment discontinuation.
    • Having a mental health problem increases the risk of physical ill health: co-morbid depression doubles the risk of coronary heart disease in adults and increases the risk of mortality by 50 per cent.
    • Medication side effects are:
      • Common, e.g. metabolic syndrome and extrapyramidal side effects
      • Potentially severe, e.g. neuroleptic malignant syndrome, lithium toxicity and cardiomyopathies.
      • Cardiovascular risk increases after first exposure to any antipsychotic drug, 65
    • In people with severe mental health problems, there is increased occurrence of:
      • Diabetes (prevalence of, at least, 15 per cent in people with schizophrenia, 5 per cent in the general population). This may also be culturally influenced.
      • Cardiovascular disease
      • Hyperlipidaemia
      • Chronic obstructive pulmonary disease (COPD)
      • Bowel cancer
      • Venous thrombosis and pulmonary emboli
Summarised in an Academy of Royal Colleges publication66 types of physical health problems associated with mental ill health include:

    • Major depression doubles the lifetime risk of developing Type 2 diabetes
    • Standardised mortality rates for older people with depression is two to three times higher if untreated or unresolved
    • People with schizophrenia are three to four times more likely to develop bowel cancer
    • People with schizophrenia have a 52 per cent increased risk of developing breast cancer.
Co-morbid health anxieties or mental health disorders are associated with:

    • Poorer objective health outcomes
    • Poorer subjective health outcomes
    • Higher use of healthcare resources
    • Wider costs of, for example, lack of employment, sickness absence, informal family care and support.
Many individuals do not have physical and psychological needs met through:

    • The continued stigma of mental health problems
    • Physical explanations may be more acceptable and understandable
    • A continued lack of expertise and training in psychological assessment, management and mindedness for many practitioners
    • Inadequate service design and provision
    • Lack of integrated ‘whole person’ commissioning structures and provider organisations
NICE clinical guidelines for schizophrenia and bipolar disorders 67-68 include recommendations for physical healthcare, and within regular case reviews, community mental health services are expected to ensure access to regular physical health checks and healthcare.

What do service users and carers think?
Service users and carers consistently highlight the importance of physical health needs and the relative neglect of them by services. Often this is stigma-related – assumptions are made that physical symptoms experienced are psychologically determined and screening and investigation is either not done or done inadequately.

Service user views of current medication, e.g. antipsychotics and mood stabilisers, are often negative even though they may accept the need to take them. Of those settled on the former, 70% discontinued them over an eighteen month period. There is a view that effectiveness has been over- and adverse effects under-stated and that choice of intervention needs to be widened.

What works?
The range of care across the pathway includes:

    • Primary care management of ‘active monitoring’ and positive diagnosis, management of common mental health problems, guided self-help strategies and programmes, motivational interviewing.
    • Psychological interventions at the primary/ secondary care interface, including integrated/stepped/collaborative care models with planned and coordinated care, interdisciplinary working and clear access points to services.
    • Interventions for those with severe problems to improve physical health, e.g. smoking cessation69 averting weight gain [CBT] and weight reduction.70
    • Invitation letters for physical health checks may be responded by more than 60% of those with severe problems. 71
    • Psychological care input into long-term conditions and acute hospital multidisciplinary teams.
    • Development of liaison psychiatry services in acute hospitals to provide assessment, treatment, advice, consultation and management of complex cases.
Outcomes can be improved:

    • If health promotion programmes specifically address the common relevant issues; poor attention, concentration and motivation, social anxiety and fear and suspicion of other people. People with mental health problems are less likely to benefit from mainstream screening and public health programmes.
    • Regular health checks can also improve detection rates but those who need them most are least likely to access them. Closer links between primary and secondary care e.g. assertive outreach teams bringing service users to primary care or facilitating home visits can substantially improve detection and support intervention 72.
    • Pro-active ‘recovery-focussed’ prescribing can reduce metabolic and other side effects.
    • ‘Hand-held’ records shared between primary and secondary care for psychosis do not seem to work nor do primary care facilitators.
    • Collaborative working with secondary care mental health services has the potential to improve health care (see Case for Change: Severe Problems).
      • Community mental health teams can engage with people with long-term mental health problems; care coordinators and/or Support, Treatment and Recovery workers can bring them to health centres or facilitate home visiting
      • Assertive outreach teams have been shown to be able to engage the most difficult group of patients and can similarly collaborate with primary care
What is actually available?
Good practice in managing the physical health care of people with severe mental illness abounds but falls far short of being comprehensively provided through:

    • Use of effective screening tools
    • Provision of extensive information
    • Collaborations between primary care and mental health services
    • Access to primary care in all settings including long-term, e.g. rehabilitation and forensic, facilities
Payment-by-results
    • PES (‘MUS’) and LTCs can present problems with ‘common mental disorders’ (Clusters 1-5) & with emotional difficulties (‘personality disorders’)(6-8). These, psychoses & bipolar disorders(10-17) can cause major complications with:
      • Acceptance of illness
      • Medication adherence
      • Acceptance of operative procedures and aftercare
      • Dietary and lifestyle adjustments
    • Evidence-based treatments are defined in relevant NICE guidelines
NICE Guidelines for Mental Health & Physical Health

Guide to links:

1. Homepage of the guidelines for the specific disorder
2. NICE guidelines for the disorder
3. Full guidelines for the disorder

Condition Link
Schizophrenia (CG1) (replaced by CG82)

http://guidance.nice.org.uk/CG1 /http://guidance.nice.org.uk/CG82

http://guidance.nice.org.uk/CG82/NICEGuidance/pdf/English

http://guidance.nice.org.uk/CG82/Guidance
Eating disorders (CG9)

http://guidance.nice.org.uk/CG9

http://guidance.nice.org.uk/CG9/NICEGuidance/pdf/English

http://guidance.nice.org.uk/CG9/Guidance/pdf/English
Self-harm

(Short term: CG16)

(Long term: CG133)
http://guidance.nice.org.uk/CG16

http://guidance.nice.org.uk/CG133/NICEGuidance/pdf/English

http://guidance.nice.org.uk/CG16/Guidance/pdf/English

Anxiety (CG22) (replaced by CG113)

http://guidance.nice.org.uk/CG22 /http://guidance.nice.org.uk/CG113

http://guidance.nice.org.uk/CG113/NICEGuidance/pdf/English

http://guidance.nice.org.uk/CG113/Guidance

Depression (CG23) (replaced by CG90)

http://guidance.nice.org.uk/CG23/ http://guidance.nice.org.uk/CG90

http://guidance.nice.org.uk/CG90/NICEGuidance/pdf/English

http://guidance.nice.org.uk/CG90/Guidance

Violence (CG25)

http://guidance.nice.org.uk/CG25

http://guidance.nice.org.uk/CG25/NICEGuidance/pdf/English

http://guidance.nice.org.uk/CG25/Guidance

Post-traumatic stress disorder (PTSD) (CG26)

http://guidance.nice.org.uk/CG26

http://guidance.nice.org.uk/CG26/NICEGuidance/pdf/English

http://guidance.nice.org.uk/CG26/Guidance

Obsessive compulsive disorder (OCD) and body dysmorphic disorder (BDD) (CG31)

http://guidance.nice.org.uk/CG31

http://guidance.nice.org.uk/CG31/NICEGuidance/pdf/English

http://guidance.nice.org.uk/CG31/Guidance

Bipolar disorder (CG38)

http://guidance.nice.org.uk/CG38

http://guidance.nice.org.uk/CG38/NICEGuidance/pdf/English

http://guidance.nice.org.uk/CG38/Guidance

Antisocial personality disorder (CG77)

http://guidance.nice.org.uk/CG77

http://guidance.nice.org.uk/CG77/NICEGuidance/pdf/English

http://guidance.nice.org.uk/CG77/Guidance

Borderline personality disorder (BPD) (CG78)

http://guidance.nice.org.uk/CG78

http://guidance.nice.org.uk/CG78/NICEGuidance/pdf/English

http://guidance.nice.org.uk/CG78/Guidance

Depression with a chronic physical health problem (CG91)

http://guidance.nice.org.uk/CG91

http://guidance.nice.org.uk/CG91/NICEGuidance/pdf/English

http://guidance.nice.org.uk/CG91/Guidance

Delirium (CG103)

http://guidance.nice.org.uk/CG103

http://guidance.nice.org.uk/CG103/NICEGuidance/pdf/English

http://guidance.nice.org.uk/CG103/NICEGuidance/pdf/English

Common mental health disorders: depression, GAD, panic disorder, OCD, PTSD, and social anxiety disorder (CG123)

http://guidance.nice.org.uk/CG123

http://guidance.nice.org.uk/CG123/NICEGuidance/pdf/English

http://guidance.nice.org.uk/CG123/Guidance

Service user experience in adult mental health (CG136)

http://guidance.nice.org.uk/CG136

http://guidance.nice.org.uk/CG136/NICEGuidance/pdf/English

http://guidance.nice.org.uk/CG136/Guidance

Autism in adults (CG142)

http://guidance.nice.org.uk/CG142

http://guidance.nice.org.uk/CG142/NICEGuidance/pdf/English

http://guidance.nice.org.uk/CG142/Guidance




Technology Appraisal Guidance
Guide to links:

1. Homepage of the topic
2. Full guidance

Topic Link
Schizophrenia - atypical antipsychotics (TA43) (replaced by CG82)

http://guidance.nice.org.uk/CG82

http://guidance.nice.org.uk/CG82/NICEGuidance/pdf/English

http://guidance.nice.org.uk/CG82/Guidance
Bipolar disorder - new drugs (TA66) (replaced by CG38)

http://guidance.nice.org.uk/TA66 / http://guidance.nice.org.uk/CG38

http://guidance.nice.org.uk/CG38/NICEGuidance/pdf/English

http://guidance.nice.org.uk/CG38/Guidance



References
1. Mense S, Simmonds S, Russel J. Muscle pain: understanding its nature, diagnosis and treatment. Philadelphia, USA: Lippincott Williams & Wilkins, 2001.
2. Nimnuan C, Hotopf M, Wessely S. Medically unexplained symptoms: An epidemiological study in seven specialities. Journal of Psychosomatic Research 2001;51(1):361-67. http://www.ncbi.nlm.nih.gov/pubmed/11448704
3. Peveler R, Kilkenny L, Kinmonth AL. Medically unexplained physical symptoms in primary care: a comparison of self-report screening questionnaires and clinical opinion. Journal of Psychosomatic Research 1997;47(3):245-52. http://www.ncbi.nlm.nih.gov/pubmed/9130181.
4. Howard C, Dupont S, Haselden B, Lynch J, Wills P. The effectiveness of a group cognitive-behavioural breathlessness intervention on health status, mood and hospital admissions in elderly patients with chronic obstructive pulmonary disease. Psychology, Health & Medicine 2010;15(4):371-85. http://www.ncbi.nlm.nih.gov/pubmed/20677076
http://www.tandfonline.com/doi/abs/10.1080/13548506.2010.482142?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed.
5. Burton C. Beyond somatisation: A review of the understanding and treatment of medically unexplained physical symptoms (MUPS). British Journal of General Practice 2003;53(488):231-39. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1314551/.
6. Salmon P, Peters S, Stanley I. Patients' perceptions of medical explanations for somatisation disorders: qualitative analysis. British Medical Journal 1999;318:372-76. http://www.bmj.com/content/318/7180/372.pdf+html.
http://www.iapt.nhs.uk/services/positive-practice-guides/?keywords=Medically unexplained symptoms positive practice guide.
8. Bermingham SL, Cohen A, Haque J, Parsonage M. The cost of somatisation among the working-age population in England for the year 2008-2009. Mental Health in Family Medicine 2010;7(2):71-84. http://www.ncbi.nlm.nih.gov/pubmed/22477925
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939455/.
9. Goldberg D, Gask L, O'Dowd T. The treatment of somatisation: Teaching techniques of reattribution. Journal of Psychosomatic Research 1989;33(6):689-95. http://www.ncbi.nlm.nih.gov/pubmed/2621672
http://www.sciencedirect.com/science/article/pii/0022399989900846.
10. Morriss R, Dowrick C, Salmon P, Peters S, et al. Cluster randomised controlled trial of training practices in reattribution for medically unexplained symptoms. British Journal Psychiatry 2007;191:536-42. http://www.ncbi.nlm.nih.gov/pubmed/18055958
http://www.google.co.uk/url?sa=t&rct=j&q=&esrc=s&frm=1&source=web&cd=2&ved=0CFYQFjAB&url=http://bjp.rcpsych.org/content/191/6/536.full.pdf&ei=c8sbUO7qO8HW0QWItYDgBA&usg=AFQjCNEeUy9cJKZ7vWzZ3wjcCUYK5ROLWw&sig2=9Ktpp2RweZF7E_iQ3W050A.
11. Dawson AM, Creed FH. The psychological care of medical patients: Recognition of need and service provision: Royal College of Physicians and Royal College of Psychiatrists (Joint Report CR35), 1995. http://www.ncbi.nlm.nih.gov/pubmed/7658413.
12. Castell BD, Kazantzis N, Moss-Morris RE. Cognitive behavioral therapy and graded exercise for chronic fatigue syndrome: A meta-analysis. Clinical Psychology: Science and Practice 2011;18(4):311-24. http://onlinelibrary.wiley.com/doi/10.1111/j.1468-2850.2011.01262.x/abstract.
13. Spiller R, Aziz Q, Creed F, Emmanuel A, et al. Guidelines on irritable bowel syndrome: Mechanisms and practical management. Gut 2007;56(12):1770-98. http://www.ncbi.nlm.nih.gov/pubmed/17488783
http://www.google.co.uk/url?sa=t&rct=j&q=&esrc=s&frm=1&source=web&cd=1&ved=0CFoQFjAA&url=http://www.bsg.org.uk/pdf_word_docs/ibs.pdf&ei=wdEbUPvAFcOh0QWqjYHwDA&usg=AFQjCNFsguMC45R3KJT5Alopuw6coIQZ1g&sig2=PBvaBEAZLsCu9ruy8VC3nA.
14. Hauser W, Eich W, Hermann M, Nutzinger DO, et al. Clinical Practice Guideline. Fibromyalgia Syndrome: Classification, Diagnosis, and Treatment, 20090. 10.3238/arztebl.2009.0383.
15. Sattel H, Lahmann C, Gundel H, Guthrie E, et al. Brief psychodynamic interpersonal psychotherapy for patients with multisomatoform disorder: Randomised controlled trial. The British Journal of Psychiatry 2012;200(1):60-67. http://www.ncbi.nlm.nih.gov/pubmed/22075651
http://bjp.rcpsych.org/content/200/1/60.long.
16. Gask L, Bower P, Lamb J, Burroughs H, et al. Improving access to psychosocial interventions for common mental health problems in the United Kingdom: narrative review and development of a conceptual model for complex interventions BMC Health Services Research 2012;12:249-49. http://www.biomedcentral.com/1472-6963/12/249/abstract.
17. Bermingham, et al. The cost of somatisation among the working age population in England for the year 2008-2009 39. Mental Health in Family Medicine 2010;7(2):71-84.
18. Joint Commissioning Panel for Mental H. Guidance for commissioners of primary mental health care services. London: The Royal College of Psychiatrists, 2012.
19. Confederation NHS. Healthy mind, healthy body: How liaison psychiatry services can transform quality and productivity in acute settings, 20090. www.nhsconfed.org/Publications.
http://dementia.dh.gov.uk/dementia-commissioning-pack/, 2012.
21. Wong M. Report on CLAHRC project: a service design approach to frequent attendance in the emergency department - personal communication: NHS Confederation, 2011. http://www.google.co.uk/url?sa=t&rct=j&q=&esrc=s&frm=1&source=web&cd=5&ved=0CFYQFjAE&url=http://www.nhsconfed.org/Publications/Documents/Investing%20in%20emotional%20and%20psychological%20wellbeing%20for%20patients%20with%20long-tern%20conditions%2018%20April%20final%20for%20website.pdf&ei=19MbULLOM4Gt0QWPrYHoDg&usg=AFQjCNGB78Do6GpTam2sNr4gvvjRF4vSyg&sig2=Oey9tTZuWwZcu-D4nTmeQA.
22. Department of H. Raising the profile of long-term conditions care: a compendium of information 40: Department of Health Gateway Reference 3734., 20080.
23. Joint Commissioning Panel for Mental H. Guidance for commissioners of primary mental health care services. London: Department of Health, 2012. http://www.rcpsych.ac.uk/policy/policyandparliamentary/projects/live/commissioning.aspx.
24. Davidson KW, Kupfer DJ, Bigger JT, Califf RM, et al. Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report. Psychosomatic Medicine 2006;68(5):645-50. http://www.ncbi.nlm.nih.gov/pubmed/17012516
http://www.google.co.uk/url?sa=t&rct=j&q=&esrc=s&frm=1&source=web&cd=4&ved=0CFcQFjAD&url=http://www.psychosomaticmedicine.org/content/68/5/645.full.pdf&ei=SJUbUI6uDLSN0wWr64GIBA&usg=AFQjCNH2sh5CoDXDAuoSkJGQ6pCQtbe0xg&sig2=aGFHxew-NQQIfM6Z7PY-TQ.
25. Barth J, Schumacher M, Herrmann-Lingen L. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosomatic Medicine 2004;66(6):802-13. http://www.ncbi.nlm.nih.gov/pubmed/15564343
http://www.psychosomaticmedicine.org/content/66/6/802.long.
26. Chetta A, Foresi A, Marangio S, Olivieri D. Psychological implications of respiratory health and disease. Respiration 2005;72(2):210-15. http://www.ncbi.nlm.nih.gov/pubmed/15824535
http://content.karger.com/produktedb/produkte.asp?DOI=10.1159/000084056.
27. van Manen J, Bindels P, Dekker F, et al. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax 2002;57:412-16. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1746339/.
28. Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly patients with chronic obstructive pulmonary disease. Age and ageing 2006;35(5):457-59. http://www.ncbi.nlm.nih.gov/pubmed/16638758
http://ageing.oxfordjournals.org/content/35/5/457.long.
29. Kim H, Kunik M, Molinari V, Hillman S, et al. Functional Impairment in COPD Patients: The Impact of Anxiety and Depression. Psychosomatics 2000;41:465-71. http://www.ncbi.nlm.nih.gov/pubmed/11110109.
30. Frasure-Smith N, Lesperance F, Juneau M, Talajic M, Bourassa MG. Gender, depression and one-year prognosis after myocardial infarction. Psychosomatic Medicine 1999;61(1):26-37. http://www.ncbi.nlm.nih.gov/pubmed/10024065
http://www.psychosomaticmedicine.org/content/61/1/26.short.
31. Dickens C, McGowan L, Percival C, Tomenson B, et al. New onset depression following myocardial infarction predicts cardiac mortality. Psychosomatic Medicine 2008;70(4):450-55. http://www.ncbi.nlm.nih.gov/pubmed/18434496
http://www.psychosomaticmedicine.org/content/70/4/450.full.pdf html.
32. Chilcot J, Wellsted D, Farrington K. Depression in end-stage renal disease: current advances and research. Seminars in Dialysis 2010;23(1):74-82. http://www.ncbi.nlm.nih.gov/pubmed/19747172
http://onlinelibrary.wiley.com/doi/10.1111/j.1525-139X.2009.00628.x/pdf.
33. McGillion M, Arthur H, Victor JC, Watt-Watson J, Cosman T. Effectiveness of psychoeducational interventions for improving symptoms, health-related quality of life, and psychological wellbeing in patients with stable angina. Current Cardiology Reviews 2008;4(1):1-11. http://www.ncbi.nlm.nih.gov/pubmed/19924272
http://ukpmc.ac.uk/abstract/MED/19924272.
34. Lewin RJ, Furze G, Robinson J, Griffith K, Wiseman S, Pye M, et al. A randomised controlled trial of a self-management plan for patients with newly diagnosed angina. British Journal of General Practice 2002;52(476):199-201. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1314238/.
http://guideline.gov/content.aspx?id=15522, 2009. http://guideline.gov/content.aspx?id=15522.
36. Katon W, Unutzer J, Fan MY, Williams JW, et al. Cost effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression. Diabetes Care 2006;29(2):265-70. http://www.ncbi.nlm.nih.gov/pubmed/16443871
http://care.diabetesjournals.org/content/29/2/265.long.
37. Gunn J, Diggens J, Hegarty K, Blashki GA. A systematic review of complex system interventions designed to increase recovery from depression in primary care. BMC Health Services Research 2006;6:88. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1559684/.
38. Alam R, Sturt J, Lall R, Winkley K. An updated meta-analysis to assess the effectiveness of psychological interventions delivered by psychological specialists and generalist clinicians on glycaemic control and on psychological status. Patient Education and Counselling 2008;75(1):25-36. http://www.ncbi.nlm.nih.gov/pubmed/19084368
http://www.sciencedirect.com/science/article/pii/S0738399108004795.
39. Ismail K, Winkley K, Rabe-Hesketh S. Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes. The Lancet 2004;363:1589-97. http://www.ncbi.nlm.nih.gov/pubmed/15145632
http://www.sciencedirect.com/science/article/pii/S0140673604162028.
40. Diabetes NHS, Diabetes UK. Emotional and psychological care and treatment in diabetes 41. London: NHS Diabetes and Diabetes UK, 2010.
41. Graham I, Atar D, Borch-Johnsen K, Boysen G, et al. European guidelines on cardiovascular disease prevention in clinical practice. European Journal of Cardiovascular Prevention and Rehabilitation 2007;14(Suppl. 2):S1-S113. http://www.ncbi.nlm.nih.gov/pubmed/17726407.
42. Davies SJ, Jackson PR, Potokar J, Nutt DJ. Treatment of anxiety and depressive disorders in patients with cardiovascular disease. British Medical Journal 2004;328:939-43. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC390215/.
43. Moore RK, Groves DG, Bridson JD, Grayson AD, et al. A brief cognitive-behavioural intervention reduces admission in refractory angina patients. Journal of Pain Symptom Management 2007;33(3):310-16. http://www.ncbi.nlm.nih.gov/pubmed/17349500
http://www.sciencedirect.com/science/article/pii/S0885392406007214.
44. Baumeister H, Hutter N, Bengel J. Psychological and pharmacological interventions for depression in patients with coronary artery disease. Cochrane Database of Systematic Reviews 2011;2011(9):CD008012. http://www.ncbi.nlm.nih.gov/pubmed/21901717
http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008012.pub3/pdf.
45. Confederation NHS. Investing in emotional and psychological wellbeing for patients with long-term conditions. London: NHS Confederation, 2012.
46. Simon GE, Katon WJ, Lin EH, Ludman E, et al. Diabetes complications and depression as predictors of health service costs. General Hospital Psychiatry 2005;27(5):344-51. http://www.ncbi.nlm.nih.gov/pubmed/16168795
http://www.sciencedirect.com/science/article/pii/S0163834305000642.
http://www.iapt.nhs.uk/about-iapt/w...occupational-standards/?keywords=competencies.
48. Joint Commissioning Panel for Mental H. Guidance for commissioners of liaison mental health services to acute hospitals 1, 20120. http://www.rcpsych.ac.uk/policyandparliamentary/projects/live/commissioning/volumetwo.aspx.
49. Evans ME, Hammond M, Wilson K, Lye M, Copeland J. Placebo controlled treatment trial of depression in elderly physically ill patients. International Journal of Geriatric Psychiatry 1997;12(8):817-24. http://www.ncbi.nlm.nih.gov/pubmed/9283926
http://onlinelibrary.wiley.com/doi/10.1002/(SICI)1099-1166(199708)12:8%3C817::AID-GPS645%3E3.0.CO;2-4/abstract
50. Baldwin DS, et al. Effectiveness of liaison psychiatric nursing in older medical inpatients with depression: randomised controlled trial. Age Ageing 2007;36:436-42.
51. Cole MG, Fenton FR, Engelsmann F, Mansouri I. Effectiveness of geriatric consultation in acute hospital. Journal of the American Geriatrics Society 1991;39:1183-88. http://www.ncbi.nlm.nih.gov/pubmed/1960363.
52. Strain JJ, Lyons JS, Hammer JS, Fahs M, et al. Cost offset from a psychiatric consultation-liaison intervention with elderly hip fracture patients. American Journal of Psychiatry 1991;148(8):1044-49. http://www.ncbi.nlm.nih.gov/pubmed/1853954
http://ajp.psychiatryonline.org/article.aspx?volume=148&page=1044.
53. Kommiski, et al. Survival in the community of the very old discharged from medical inpatient care. International Journal of Geriatric Psychiatry 2007.
54. Katon WJ. Clinical and health services relationships between major depression, depressive symptoms and general medical illness. Biological Psychiatry 2003;54(3):216-26. http://www.ncbi.nlm.nih.gov/pubmed/12893098
http://www.sciencedirect.com/science/article/pii/S0006322303002737.
55. Creed F, Morgan R, Fiddler M, Marshall S, et al. Depression and anxiety impair health-related quality of life and are associated with increased costs in general medical inpatients. Psychosomatics 2002;43(4):302-09. http://www.ncbi.nlm.nih.gov/pubmed/12189256.
56. Royal College of P. Who cares wins. Improving the outcome of older people admitted to the general hospitals. Guidelines for the development of liaison mental health services for older people, 20050. www.rcpsych.ac.uk/PDF/WhoCaresWins.pdf.
57. Naylor C, Parsonage M, McDaid D, Knapp M, Fossey M, Galea A. Long-term conditions and mental health: The cost of co-morbidities: The Kings Fund, 20120. www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsLegislation/DH_123984.
59. McCrone P, Sharpe M, Chalder T, Knapp M, Johnson AL, Goldsmith KA, et al. Adaptive pacing, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome: a cost-effectiveness analysis. PloS one 2012;7(8):e40808. http://www.ncbi.nlm.nih.gov/pubmed/22870204.
www.nhsconfed.org/Publications.
www.centreformentalhealth.org.uk.
www.dh.gov.uk/en/Healthcare/Mentalhealth/MentalHealthStrategy/index.htm
http://www.google.co.uk/url?sa=t&rct=j&q=&esrc=s&frm=1&source=web&cd=5&ved=0CGEQFjAE&url=http://www.iapt.nhs.uk/silo/files/no-health-without-mental-health.pdf&ei=fdsbUP-wMIaZ0QW90YHwCA&usg=AFQjCNHQudwrfFkEFVDd2dc5YOUpKXjuuQ&sig2=55arUYAk_VWnsdK8ZzqgcQ.
63. Curtis J, Henry C, Watkins A, Newall H, Samaras K, Ward PB. Metabolic abnormalities in an early psychosis service: A retrospective, naturalistic cross-sectional study. Early Intervention in Psychosis 2011;5(2):108-14. http://www.ncbi.nlm.nih.gov/pubmed/21470374
http://onlinelibrary.wiley.com/doi/10.1111/j.1751-7893.2011.00262.x/pdf.
64. Newall H, Myles N, Ward P, et al. Efficacy of metformin for prevention of weight gain in psychiatric populations: a review. International Clinical Psychopharmacology 2012;27:69-75.
65. Foley DL, Morley KI. Systematic review of the cardiometabolic outcomes of the first treated episode of psychosis. Archives of General Psychiatry 2011;68(6):609-16. http://www.ncbi.nlm.nih.gov/pubmed/21300937
http://archpsyc.jamanetwork.com/article.aspx?articleid=211318.
www.rcpsych.ac.uk/pdf/No%20Health%20without%20mental%20health%20the%20Evidence.pdf.
www.nice.org.uk/cg38.
www.nice.org.uk/cg82.
69. Tsoi DT, Porwal M, Webster AC. Efficacy and safety of bupropion for smoking cessation and reduction in schizophrenia: systematic review and meta-analysis. British Journal of Psychiatry 2010;196(5):346-53. http://www.ncbi.nlm.nih.gov/pubmed/20435957
http://bjp.rcpsych.org/content/196/5/346.long.
70. Holt RIG, Pendlebury J, Wildgust HJ, Bushe CJ. Intentional weight loss in overweight and obese patients with severe mental illness: 8-year of a behavioural treatment programme. Journal of Clinical Psychiatry 2008;71(6):800-05. http://www.ncbi.nlm.nih.gov/pubmed/20361917.
71. Hardy S, Gray R. Is the use of an invitation letter effective in prompting patients with severe mental illness to attend a primary care physical health check? Primary Health Care Research & Development 2012;20:1-6. http://www.ncbi.nlm.nih.gov/pubmed/22340012.
72. Lester HA, Shiers DE, Rafi I, Cooper SJ, Holt R. Positive cardiometabolic health resource: An intervention framework for patients with psychosis on antipsychotic medication. Clinical resource developed between RCGP and College Centre for Clinical Improvements of the Royal College of Psychiatrists. London: Royal College of Psychiatrists, 2012.

Last Updated on Thursday, 13 September 2012 08:29
 
Last edited:

Legendrew

Senior Member
Messages
541
Location
UK
I like the idea of them finally admitting that there are things which medicine has no answer for as of yet but I think that this would just create an even bigger umbrella term and make distinguishing different disease even more difficult! Not to mention psychologists would likely have a field day.
 

biophile

Places I'd rather be.
Messages
8,977
I haven't read it all, but it is a bit rich to confidently claim that the MUPS are explainable by functional physiological processes, when the explanations are often based on unproven speculation or assumptions, and the diagnoses are made without any testing or research to confirm that these physiological processes are actually causing the patients' symptoms.

Claiming that lactate build-up in muscles is a prime example of "very well established physiological explanations of stress on the body" that causes "cramp or tiredness", as far as I remember, this has been busted or disputed in recent years. However, I suspect many within the biopsychosocial movement aren't too fussed about the truth if they think the speculation will help patients report less problems or be less of a burden on the system. On the other hand, if patients find out the explanation given to them is flawed or inaccurate, they might start questioning the competence of their health care providers.

Hyperventilation can cause "giddiness or tingling", but so can many other conditions, and dismissing these symptoms as hyperventilation could overlook the presence of problems such as autonomic dysfunction and neuropathy.

Symptom re-attribution may reduce anxiety but it generally won't make the problem go away if it is ME or CFS, and can make the problem worse if the patient erroneously believes they can start exercising their way to health.
 
Last edited:

Esther12

Senior Member
Messages
13,774
I like the idea of them finally admitting that there are things which medicine has no answer for as of yet but I think that this would just create an even bigger umbrella term and make distinguishing different disease even more difficult! Not to mention psychologists would likely have a field day.

I think you may be a step behind Andrew (unless I've misunderstood).

This sounds like they've gone from lumping all MUS in together and psychologists having a field day, on to claiming that all MUS should be claimed to have empowering recovery-focused explanations for them... so we don't even get the honesty about medicine not having an answer!
 

Valentijn

Senior Member
Messages
15,786
I see. It would seem that they have taken the BPS approach of redefining words to new levels.

"Explanation" now means "bullshit theory I dug out of my ass." Ergo everything is explained! :rofl:
 

peggy-sue

Senior Member
Messages
2,623
Location
Scotland
The "explanation" is no different to what it was before.

Long term uncontrollable stress leads to the breakdown of the feedback mechanism, turning it into a feedforward one resulting in clinical depression, as can be ascertained by the dexamethasone supressor test (or presence of anhedonia). That's not BS.

Clinical depression is physiological.

All they've done is change the words "medically unexplained" into "physiologically explained".

It's just more gaslighting, nothing has changed.
 

A.B.

Senior Member
Messages
3,780
Long term uncontrollable stress leads to the breakdown of the feedback mechanism, turning it into a feedforward one resulting in clinical depression, as can be ascertained by the dexamethasone supressor test (or presence of anhedonia). That's not BS.

Has it been proven that this is the cause behind depression? What you have described is merely a potential explanation.

Psychology has the tendency to be content with possibilities rather than facts.
 
Last edited:

peggy-sue

Senior Member
Messages
2,623
Location
Scotland
It was what I was taught by the Open University in '94.
Second level course, "Biology: Brain and Behavior" (SD206) Science, not psychology.

It's the dexamethasone supressor test that demonstrates the physiological breakdown of the feedback.

I'd have to go rooting in the attic for my old text books to find author references.